Bellatora Inc. (ECGR) Stock

About Bellatora Inc.

Bellatora Inc. specializes in the production, distribution, and promotion of electronic vaporizers, e-liquids, and ecigars, catering to individuals who use tobacco or medicinal cannabis. The company formerly conducted business as Oncology Med, Inc. before adopting its current name, Bellatora Inc., in September of 2016. Its primary corporate operations are based in Anaheim, California.

Bellatora Inc. is headquartered in US.

Bellatora Inc. (ECGR) stock trades at $0.80 with a market capitalization of $13.39M. The stock is valued at a negative price-to-earnings (P/E) ratio of -11.43, reflecting a net loss over the last twelve months, a negative price-to-book of -26.62, reflecting negative shareholders' equity, price-to-sales of 15.46. Over the past 52 weeks the stock has ranged between $0.41 and $1.21, and currently trades 33.9% below its 52-week high.

On profitability, Bellatora Inc. generates a return on equity (ROE) of 0.00% (not meaningful, as shareholders' equity is negative), return on capital employed of -14.00%, an operating margin of -95.42%.

Official website: www.bellatora.com